Back

Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality?

European Heart Journal

13 July 2021
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure

Contributors

Noel Chan
Noel Chan

Author

John Eikelboom
John Eikelboom

Author

You may be interested in
thumbnail
Congress Presentation
Correlation of thrombotic complications with in-hospital mortality in patients with covid-19. sub-analysis of the argentine registry of cardiovascular complications in patients with covid-19 (RACCOVID
21 May 2023
thumbnail
Congress Session
Young Investigator Award Basic and Translational Science
1 April 2025
thumbnail
Webinar
Cardiovascular involvement in COVID-19 patients: multimodality imaging for diagnosis, risk stratification and management
10 June 2021
thumbnail
Webinar
Cancer associated thrombosis: have DOACs changed daily practice?
21 September 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources